维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：作者名="Verges B"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	The impact of prandial glucose regulation in practice显示文摘	Verges B	2002	Diabetes Nutr Metab2002，15，6：	1
2	Gambert adiponectin is an important determinant of apoA-I catabolism 显示文摘	Verges B J M Petit L Duvillard G	2006	Arterioscler Thromb Vasc Biol2006，26，：	1
3	Review on depression and coronary heart disease显示文摘	Jean-Christophe Chauvet-Géliniera Benoit Trojaka Bénédicte Vergès-Patoisb	2013	Archives of Cardiovascular Diseases2013，106，2：	1
4	Impact of fasting glycemia on short-term prognosis after acute myocardial infarction 显示文摘	Verges B Zeller M Dentan G	2007	J Clin Endoerinol Metab2007，92，6：	1
5	Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects显示文摘	Guerci B Durlach V	2001	J Lipid Res2001，42，12：	1
6	Effects of cardiac rehabilitation on exercise capacity in Type 2 diabetic patients with coronary artery disease 显示文摘	VERGES B PATOIS-VERGES B COHEN M	2004	Diabet Med2004，21，8：	1
7	Non-ultra- sound-guided ethanol sclerotherapy for the treatment of thyroid cysts显示文摘	Verges B Burlier P Baillot-Rudoni S	2011	Ann Endocrinol(Paris)2011，72，3：	1
8	Strategies for insulin initiation: insights from the French LIGHT observational study显示文摘	Verges B Brun JM Tawil C	2012	Diabetes Metab Res Rev2012，28，：	1
9	Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus显示文摘	Verges B Guiu B Cercueil JP		0，，：	1
10	Beyond glucose lowering: glucagon- like peptide-I receptor agonists, body weight and the cardiovascular system 显示文摘	Verges B Bonnard C Renard E	2011	Diabetes Metab2011，37，6：	1
11	Effects of cardiac rehabilitation on exercise capacity in Type 2 diabetic patients with coronary artery disease 显示文摘	Verges B Patois-Verges B Cohen M	2004	Diabet Med2004，21，：	1
12	Hypoxia,energy balance and obesity:from pathophysiological mechanisms to new treatment strategies显示文摘	Kayser B Verges S	2013	Obesity reviews2013，14，7：	1
13	mTOR inhibitors and diabetes 显示文摘	Verges B Cariou B	2015	Diabetes Res Clin Pr2015，110，2：	1
14	ApoA5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment显示文摘	Marcais C Verges B Charriere S	2005	J Clin Invest2005，115，10：	1
15	Clinical interest of PPARs ligands显示文摘	Verges B	2004	Diabetes Metab2004，30，1：	1
16	Plasma N-terminal Pro-Brain Natritlretic Peptide (NT-proBNP)level and prognosis after myocardial infarction in diabetes 显示文摘	Verges B Zeller M	2008	Diabetes & Metabolism2008，34，：	1
17	Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation显示文摘	Persegol L Verges B Foissac M		0，，：	1
18	Lipid modification in type 2 diabetes:the role of LDL and HDL显示文摘	VERGES B	2009	Fundam Clin Pharmacol2009，23，：	1
19	ApoA5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment显示文摘	Marcais C Verges B Charriere S	2005	J Clin Invest2005，115，：	1
20	Retinol-binding protein 4 is an independent factor associated with triglycerides and a determi- nant of very low-density lipopmtein-apolipopmtein BIO0 catabolism in type 2 diabetes mellitus 显示文摘	Verges B Guiu B Cercueil ]P	2012	Artedoscler Thromb Vasc Biol2012，32，12：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示